Log In
BCIQ
Print this Print this
 

Recombinate, antihemophilic factor (Factor VIII)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionRecombinant Factor VIII (rFVIII)
Molecular Target Factor VIII
Mechanism of ActionProcoagulant
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsPerioperative management of hemophilia A; Treat hemophilia A
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today